IRIS
STRIPPOLI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.413
AS - Asia 5.075
EU - Europa 2.028
SA - Sud America 1.906
AF - Africa 250
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 5
Totale 25.698
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.286
SG - Singapore 2.232
BR - Brasile 1.649
CN - Cina 1.045
HK - Hong Kong 915
SE - Svezia 481
RU - Federazione Russa 427
VN - Vietnam 354
GB - Regno Unito 236
DE - Germania 187
IT - Italia 147
CI - Costa d'Avorio 119
IN - India 115
AR - Argentina 103
UA - Ucraina 95
FI - Finlandia 85
BD - Bangladesh 65
BE - Belgio 56
FR - Francia 54
ID - Indonesia 52
EC - Ecuador 50
ZA - Sudafrica 50
CA - Canada 48
IQ - Iraq 45
MX - Messico 45
NL - Olanda 39
AT - Austria 37
TR - Turchia 35
PY - Paraguay 27
JP - Giappone 26
IE - Irlanda 25
MA - Marocco 25
PK - Pakistan 24
EE - Estonia 23
UZ - Uzbekistan 21
AU - Australia 20
CO - Colombia 20
ES - Italia 20
PL - Polonia 20
VE - Venezuela 20
IL - Israele 19
EG - Egitto 18
SA - Arabia Saudita 17
CL - Cile 14
JO - Giordania 11
KE - Kenya 11
LT - Lituania 11
NP - Nepal 10
PE - Perù 10
PH - Filippine 10
CZ - Repubblica Ceca 9
PT - Portogallo 9
TH - Thailandia 9
AZ - Azerbaigian 8
BO - Bolivia 8
AE - Emirati Arabi Uniti 7
HU - Ungheria 7
RO - Romania 7
RS - Serbia 7
BG - Bulgaria 6
PA - Panama 6
TW - Taiwan 6
BB - Barbados 5
BH - Bahrain 5
CH - Svizzera 5
DK - Danimarca 5
DZ - Algeria 5
JM - Giamaica 5
MK - Macedonia 5
MY - Malesia 5
UY - Uruguay 5
GE - Georgia 4
IR - Iran 4
KR - Corea 4
KZ - Kazakistan 4
ME - Montenegro 4
OM - Oman 4
SN - Senegal 4
TN - Tunisia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
HN - Honduras 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
BS - Bahamas 2
BY - Bielorussia 2
CG - Congo 2
CU - Cuba 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HR - Croazia 2
IM - Isola di Man 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
MN - Mongolia 2
NG - Nigeria 2
Totale 25.669
Salva come PNG Salva come JPEG
Città #
Fairfield 2.696
Ashburn 1.589
Chandler 1.530
Woodbridge 1.364
Houston 1.177
Singapore 1.158
Seattle 1.138
Cambridge 1.123
Hong Kong 907
Wilmington 879
Beijing 418
Ann Arbor 409
Nyköping 383
Lawrence 299
Roxbury 294
Des Moines 212
Jacksonville 204
Dallas 185
New York 178
Ho Chi Minh City 138
Los Angeles 133
Abidjan 119
San Diego 114
São Paulo 113
Inglewood 106
Dearborn 98
The Dalles 94
Columbus 85
Santa Clara 83
Nanjing 74
Hanoi 73
Buffalo 71
Brussels 56
Munich 56
London 53
Rio de Janeiro 53
Chicago 48
Falls Church 46
Washington 44
Brooklyn 40
Belo Horizonte 39
Council Bluffs 39
Boardman 37
Moscow 34
Nuremberg 34
Pune 34
Hefei 30
Bari 29
Guangzhou 29
Guayaquil 28
Paris 27
Porto Alegre 27
Stockholm 27
Johannesburg 26
Princeton 26
Tokyo 26
Dublin 25
Edinburgh 25
San Jose 25
Curitiba 24
Helsinki 24
Salvador 23
San Francisco 23
Dhaka 22
Guarulhos 22
Jakarta 22
Kunming 22
Baghdad 21
Shanghai 21
Vienna 21
Hebei 20
Turku 20
Brasília 19
Jinan 19
Nanchang 19
Tashkent 19
Warsaw 19
Changsha 18
Redwood City 17
Amsterdam 16
Jiaxing 16
Kilburn 16
Atlanta 15
Boston 15
Goiânia 15
New Delhi 15
Ribeirão Preto 15
Salt Lake City 15
Campinas 14
Osasco 14
Toronto 14
Zhengzhou 14
Giza 13
Haiphong 13
Hounslow 13
Manaus 13
Shenyang 13
Wuhan 13
Asunción 12
Bauru 12
Totale 19.118
Salva come PNG Salva come JPEG
Nome #
The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial 195
A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study 194
Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop 170
An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism 163
Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials 163
Catheter-related interventions to prevent peritonitis in peritoneal dialysis: A systematic review of randomized, controlled trials 150
Addition of the Multidimensional Prognostic Index to the Estimated Glomerular Filtration Rate Improves Prediction of Long-Term All-Cause Mortality in Older Patients with Chronic Kidney Disease 147
Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis 142
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease 141
Aldosterone antagonists for preventing the progression of chronic kidney disease 137
HMG CoA reductase inhibitors (statins) for kidney transplant recipients 135
Robotic Versus Laparoscopic Minimally Invasive Surgery for Rectal Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials 134
Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study 133
Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease 132
Antiplatelet agents for chronic kidney disease 129
Mesalazine for people with diverticular disease: A systematic review of randomized controlled trials 129
Aldosterone antagonists for preventing the progression of chronic kidney disease 127
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials 125
Fluid intake and all-cause mortality, cardiovascular mortality and kidney function: A population-based longitudinal cohort study 122
Antihypertensive agents for preventing diabetic kidney disease 122
Primary cerebral lymphoma and membranous nephropathy: a still unreported association 121
Thyroid hormones for acute kidney injury 121
Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials 119
Risk of death following kidney allograft failure: A systematic review and meta-analysis of cohort studies 119
Antimicrobial agents to prevent peritonitis in peritoneal dialysis: A systematic review of randomized controlled trials 117
Proteinuria: Does vitamin D treatment improve outcomes in CKD? 115
Patient satisfaction with in-centre haemodialysis care: An International Survey 115
Oral mucosal lesions and risk of all-cause and cardiovascular mortality in people treated with long-term haemodialysis: The ORAL-D multinational cohort study 114
Induction and maintenance treatment of proliferative lupus nephritis: A meta-analysis of randomized controlled trials 114
Clinician beliefs and attitudes about home haemodialysis: A multinational interview study 114
How to read critically a prognostic cohort study 113
A pegylated epoetin in anaemia of renal disease: non-inferiority for an unvalidated surrogate 112
Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials 110
Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need 110
Prevalence and Correlates of Self-Reported Sexual Dysfunction in CKD: A Meta-analysis of Observational Studies 109
Quality of reporting of randomization methodology in nephrology trials 109
Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy 108
Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir 107
Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta-Analysis 106
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review 105
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients 105
Healthy dietary patterns and risk of mortality and ESRD in CKD: A meta-analysis of cohort studies 104
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: A network meta-analysis 104
Associations between hemodialysis access type and clinical outcomes: A systematic review 104
Benefits and Harms of Phosphate Binders in CKD: A Systematic Review of Randomized Controlled Trials 103
Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease 103
PERIODONTITIS AND RISK OF ALL-CAUSE AND CARDIOVASCULAR MORTALITY IN ADULTS WITH END-STAGE KIDNEY DISEASE: A PROPENSITY-MATCHED STUDY 102
Vitamin D compounds for people with chronic kidney disease requiring dialysis 102
IgA Nephropathy: A Disease in Search of a Large-Scale Clinical Trial to Reliably Inform Practice 102
Current structure and organization for renal patient assistance in Italy 100
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials 100
Antiplatelet therapy to prevent hemodialysis vascular access failure: Systematic review and meta-analysis 100
The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients 100
Sunset for Statins after AURORA? 99
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients 99
Serum testosterone levels and clinical outcomes in male hemodialysis patients 99
HMG CoA reductase inhibitors (statins) for dialysis patients 98
Analysis of the factors which affect renal survival in IgA nephropathy: A cohort study 98
Treatment for peritoneal dialysis-associated peritonitis 98
HMG CoA reductase inhibitors (statins) for kidney transplant recipients 98
Immunosuppressive treatments for immunoglobulin A nephropathy: A meta-analysis of randomized controlled trials 98
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease 97
Antihypertensive agents for preventing diabetic kidney disease 97
KHA-CARI commentary on the KDIGO clinical practice guideline for lipid management in chronic kidney disease 97
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 97
Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitudinal, observational, cohort study. 96
Home versus in-centre haemodialysis for end-stage kidney disease 96
Pre-emptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients 96
Biocompatible dialysis fluids for peritoneal dialysis 96
Darbepoetin for the anaemia of chronic kidney disease 96
The Italian experience of the national registry of renal biopsies 94
Proteinuria and Clinical Outcomes in Hypertensive Patients 93
Angiotensin converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in microalbuminuric patients with one or more cardiovascular risk factors. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes randomized trial (LIRICO) 93
Sevelamer: a promising but unproven drug 93
Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: A cross-sectional analytic study 92
Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies. 92
Effects of intensive blood pressure lowering on the progression of chronic kidney disease: A systematic review and meta-analysis 92
A nephrology guide to reading and using systematic reviews of observational studies 92
Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial 92
Antihypertensive agents for primary prevention of diabetic nephropathy 91
Potassium binders for chronic hyperkalaemia in people with chronic kidney disease 91
Sexual Dysfunction in Women with ESRD Requiring Hemodialysis 90
The beliefs and expectations of patients and caregivers about home haemodialysis: An interview study 90
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease 90
Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression 89
Patients' perspectives on hemodialysis vascular access: A systematic review of qualitative studies 89
Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes a meta-analysis 89
Non-immunosuppressive treatment for IgA nephropathy 89
Cardiac Rehabilitation Programs for Chronic Heart Disease: A Bayesian Network Meta-analysis 89
Impact of icodextrin on clinical outcomes in peritoneal dialysis: A systematic review of randomized controlled trials 89
Haemoglobin targets: we were wrong, time to move on 88
Correlation of Treatment Time and Ultrafiltration Rate with Serum Albumin and C-Reactive Protein Levels in Patients with End-Stage Kidney Disease Receiving Chronic Maintenance Hemodialysis: A Cross-Sectional Study 88
Calcimimetics and other simple pharmacological interventions do not work in dialysis: What can we do about it? 88
Meta-analysis: Vitamin D compounds in chronic kidney disease 88
Glucose targets for preventing diabetic kidney disease and its progression 88
How to design a randomized controlled trial 87
Trial Quality in Nephrology: How Are We Measuring Up? 87
A population-based cohort study defines prognoses in severe chronic kidney disease 87
How to conduct a randomized trial 86
Convective versus diffusive dialysis therapies for chronic kidney failure: An updated systematic review of randomized controlled trials 86
Totale 10.824
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.755
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.755
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.526 0 0 0 0 0 155 120 390 90 434 149 188
2021/20222.410 186 357 20 80 112 152 116 88 124 115 185 875
2022/20233.106 443 347 277 304 273 329 25 440 454 21 138 55
2023/20241.117 84 186 77 28 103 304 30 126 18 28 16 117
2024/20254.545 44 73 394 171 182 427 296 331 272 293 720 1.342
2025/20264.673 1.357 284 690 1.084 964 294 0 0 0 0 0 0
Totale 26.270